Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
CNS Drugs
Published in: CNS Drugs 1/2009

01-11-2009 | CME Overview

Advances in Attention-Deficit Hyperactivity Disorder Treatment

A Focus on the Role of Noradrenergic and Alpha-2a Receptor Modulation

Published in: CNS Drugs | Special Issue 1/2009

Login to get access

Excerpt

This activity has been designed to meet the educational needs of clinical psychiatrists and neurologists treating patients with attention-deficit hyperactivity disorder (ADHD). …
Metadata
Title
Advances in Attention-Deficit Hyperactivity Disorder Treatment
A Focus on the Role of Noradrenergic and Alpha-2a Receptor Modulation
Publication date
01-11-2009
Publisher
Springer International Publishing
Published in
CNS Drugs / Issue Special Issue 1/2009
Print ISSN: 1172-7047
Electronic ISSN: 1179-1934
DOI
https://doi.org/10.2165/00023210-200923000-00001

Other articles of this Special Issue 1/2009

CNS Drugs 1/2009 Go to the issue

Evaluation Form

Advances in ADHD Treatment: A Focus on the Role of Noradrenergic and Alpha-2a Receptor Modulation

Review Article

Issues in the Management of Patients with Complex Attention-Deficit Hyperactivity Disorder Symptoms

Review Article

Toward a New Understanding of Attention-Deficit Hyperactivity Disorder Pathophysiology

CME Post-test

Post-Test Questions

Review Article

Alpha-2 Adrenergic Agonists in Children with Inattention, Hyperactivity and Impulsiveness

Review Article

Efficacy and Safety Limitations of Attention-Deficit Hyperactivity Disorder Pharmacotherapy in Children and Adults